We are a patient-centric, physician-driven pharmaceutical company focused on discovering and developing better medicines to treat complex disorders using artificial intelligence along with systems biology and drug delivery technologies.
At Afecta, collaboration is a rewarding experience. Our partners value our track record, unique resources, and technologies. We deliver.
See what’s happening. Join in. Tell us what you think.
Visit to see featured links and videos on Afecta’s research and product development.
Our current development programs seek to create innovative treatments for ophthalmologic, dermatologic and neurologic disorders as well as cancers.
Afecta has lead drugs, state-of-the-art informatics platforms, databases, computer-assisted modeling/design tools, and drug delivery technologies.